SecBot SecBot
144 ·Filed Sep 15, 2026

GMED

GLOBUS MEDICAL INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0001974078-26-000355
Actionable Insight • Neutral

This is a routine cashless option exercise by a director — not a discretionary market sale. No bearish signal. Monitor for any subsequent Form 4 filings to confirm execution, but no trading action is warranted based on this filing alone.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
GMED ▲ +2.18% at T+20d
NEUTRAL call +2.18% · α vs SPY -0.80% · entry $74.69 → $76.32
Next anchor: T+60d in 6w
Latest observation: T+28 +17.40% FF3 residual α
Entry = T+0 close
Sep 15, 2026
via day close
T+1d
+1.57%
call +1.57% · α +1.24%
$75.86
settled 6w ago
T+5d
-0.82%
call -0.82% · α -1.63%
$74.08
settled 5w ago
T+20d
+2.18%
call +2.18% · α -0.80%
$76.32
settled 14d ago
T+60d
Pending
in 6w

Price Chart

Loading chart...

Executive Summary

Director James R. Tobin filed a Form 144 notice to sell 30,000 GMED shares via a cashless option exercise, with an estimated market value of ~$2.24M. The sale is tied to option exercise mechanics, not a discretionary cash-out, and represents a modest portion of his total holdings (~$134M). The filing is routine for a director's option exercise and does not signal a change in business outlook.

Key Facts

  • Director James R. Tobin filed Form 144 to sell 30,000 shares of GMED common stock.
  • Estimated aggregate market value of the proposed sale is $2,236,000.
  • The sale is structured as a 'cashless option exercise' — shares are issued and immediately sold to cover exercise cost and taxes.
  • Tobin's total beneficial ownership after the sale is approximately $134.3M (based on the filing's reference price).
  • The filing date is September 15, 2026; the proposed sale is planned for the same day.
  • Broker handling the sale is Raymond James & Associates.

Financial Impact

Proposed sale of 30,000 shares valued at ~$2.24M, representing ~1.7% of the insider's disclosed holdings.

dilutioninsider holdings

Risk Factors

  • Insider selling, even if option-related, can be perceived negatively by the market in the short term.
  • If additional insiders file similar 144s in the coming weeks, the pattern could indicate broader selling pressure.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
70% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 6 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (GMED) — Batch item 10001974078-26-000355
Document: 0001974078-26-000355-index.html0001974078-26-000355
Document: 0001974078-26-000355.txt0001974078-26-000355
144 Filing (GMED) — Batch item 40001974078-26-000355
Document: 0001974078-26-000355-index.html0001974078-26-000355
Document: 0001974078-26-000355.txt0001974078-26-000355
10 reports for GMED
Performance horizon
33% Hit rate @ T+20 1 of 3 directional calls Went positive at some point 2 of 3 best @ T+20▲ +0.62%Sep 11, 2026
Filters
Rows
Reports for GMED — sortable, filterable
TypeNow
Oct 27, 2026
today
SC 13G/A
NEUTRAL ★ 3/10
$81.53awaiting T+20—$80.90 (−0.77%)
Oct 21, 2026
6d ago
Institutional Cluster
NEUTRAL ★ 3/10
$81.66awaiting T+20—$80.90 (−0.93%)
Sep 15, 2026
6w ago
144
NEUTRAL ★ 2/10
$74.69 $76.32▲ +2.18%▼ −0.80%$80.90 (+8.31%)
Sep 11, 2026
6w ago
Court Ruling
BULLISH ★ 6/10
$75.77 $76.24▲ +0.62%▼ −1.64%$80.90 (+6.77%)
Aug 26, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$82.54 $74.16▼ −10.15%▼ −10.05%$80.90 (−1.99%)
Jul 16, 2026
14w ago
Press Release
NEUTRAL ★ 1/10
$77.00 $85.90▲ +11.56%▲ +7.11%$80.90 (+5.06%)
Jun 4, 2026
20w ago
8-K
NEUTRAL ★ 3/10
$80.00 $80.50▲ +0.63%▼ −1.24%$80.90 (+1.13%)
Jun 4, 2026
20w ago
Court Ruling
BEARISH ★ 7/10
$80.00 $80.12▼ −0.15%▼ −1.52%$80.90 (−1.13%)
Apr 24, 2026
26w ago
DEFA14A
NEUTRAL ★ 3/10
$93.70 $85.10▼ −9.18%▼ −14.13%$80.90 (−13.66%)
Feb 24, 2026
35w ago
8-K
BULLISH ★ 8/10
$96.22 $87.35▼ −9.22%▼ −3.98%$80.90 (−15.92%)
Showing 10 of 10

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 15, 2026